| LGD-4033 |
| 4-[(2R)-2-[(1R)-2,2,2-Trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)benzonitrile |
| (CAS 1165910-22-4) |
 |
| Description： |
LGD-4033 is a selective androgen receptor modulator a novel non-steroidal, oral SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity, class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss.
|
| Product No. |
KT20169 |
| Product Name |
LGD-4033 |
| Synonyms |
|
| Formal Name |
4-[(2R)-2-[(1R)-2,2,2-Trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)benzonitrile |
| CAS Number |
1165910-22-4 |
| Molecular Formula |
C14H12F6N2O |
| Formula Weight |
338.25 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
A-966492
AG14361
Aleglitazar
AZD-2461
Balaglitazone
BMN-673
BSI-201
FH535
G007-lk
GSK3787
GW1929
GW9662
INO-1001
JW 55
L-185041
MK4827
PJ34
T0070907
UPF 1069
XAV-939
|
|
